Havana, May 9 (Prensa Latina) Cuban scientists have produced an effective and safe medicine in a suppository form for the treatment of acute hemorrhoids, based on the use of recombinant streptokinase, Granma newspaper reported today.
According to the daily, researchers from the Center for Genetic Engineering and Biotechnology (CIGB), in collaboration with the Juan Bruno Zayas Hospital in Santiago de Cuba, after several years of clinical trials in health institutions of 12 provinces, managed to register the drug in 2012 under the name of Proctokinasa.
The medicine is expected in the near future to become the most recommended therapy against hemorrhoids in this Caribbean country, as long as production capacities are sufficient, Granma said.
Unlike formulations of existing local application that focus their main action in decreasing inflammation and pain, Proctokinasa not only complies with those functions but also manages to remove blood clots present in the affected anal orifice, achieving a 75-90-percent improvement of clinical symptoms by the fifth day of treatment.
The medicine recently received one of the 2013 National Awards from the Academy of Sciences of Cuba, in the Biomedical Sciences section, and along with its contribution to resolving a frequent health problem in Cuba and worldwide, has the potential to become another exportable Cuban biotechnology product.
